Ocular Surgery News U.S. Edition Current Issue
The following articles appeared in the print edition of Ocular Surgery News U.S. Edition.
Table of Contents
- Roundtable addresses ROP screening, fellowship training efforts Eamon N. Dreisbach
-
- FDA clears investigational new drug application for wet AMD gene therapy
- FDA extends Prescription Drug User Fee Act date for macular telangiectasia type 2 therapy
- FDA grants de novo authorization to photobiomodulation device for dry AMD Anthony DeFino
- FDA grants fast track designation to oral molecule for retinopathy of prematurity Anthony DeFino
- Fluorescein pooling effect assists late lifting of LASIK flaps Steven B. Siepser, MD, FACS
- Management of macular telangiectasia type 2 may be near Diana Do, MD
- Patients in socioeconomically deprived neighborhoods more likely to have severe RRD Michela Cimberle
- Pediatric ophthalmologists review how to address vision therapy with parents Eamon N. Dreisbach
-
- VIDEO: EYP-1901 shows positive vision, treatment burden outcomes at 1 year Carl D. Regillo, MD; Anthony DeFino
- VIDEO: LASIK with Teneo for myopia, myopic astigmatism shows good results at 9 months Alex Young; George O. Waring IV, MD, FACS
- VIDEO: Oral Stargardt’s disease treatment focuses on reducing vitamin A dimerization Michel Dahan; Anthony DeFino
- Evolution of AI in ophthalmology Uday Devgan, MD
- Variety of scleral fixation techniques can replace or rescue IOL Mitchell P. Weikert, MD; Cathleen M. McCabe, MD
- Woman presents with bilateral floaters, foggy vision Noha A. Sherif, MD; Lianna Valdes, MD
- Skill needed for challenging staging, treatment of ROP Richard L. Lindstrom, MD
- New Year’s resolutions for 2025 Darrell E. White, MD
-